MGRX
Mangoceuticals, Inc.Company with tickers: MGRX
CIK
1938046
CUSIP
56270V205
Shares Outstanding
17,167,422
13F Activity (30d)
18 filings
17 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $67,864 | USD | 2026-03-31 | 10-Q | 2026-05-19 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $8,218 | USD | 2026-03-31 | 10-Q | 2026-05-19 |
| Gross Profit | $29,001 | USD | 2026-03-31 | 10-Q | 2026-05-19 |
| Operating Expenses | $3,155,327 | USD | 2026-03-31 | 10-Q | 2026-05-19 |
| Research & Development | — | ||||
| Operating Income | $-3,126,326 | USD | 2026-03-31 | 10-Q | 2026-05-19 |
| Net Income | $-3,403,150 | USD | 2026-03-31 | 10-Q | 2026-05-19 |
| EPS (Basic) | $-0.22 | USD/shares | 2026-03-31 | 10-Q | 2026-05-19 |
| EPS (Diluted) | $-0.22 | USD/shares | 2026-03-31 | 10-Q | 2026-05-19 |